Liposuction in Geneva Switzerland
The procedure can "sculpture " your body by removing extra fat from tummy, buttocks, arms, knees, cheeks and neck.. You must remember that liposuction is not an alternative for diet and exercise, it's main target is to help remove extra fat from areas in which fat reduction cannot be done successfully by dieting.
The ideal candidates for the surgery are people with normal weight, elastic skin and areas of "fat pockets" in their body. There are no age limits but older people has less elastic skin and therefore might get results that are worse then the younger patients.
Liposuction can be done by several techniques: solution injection - in which the surgeon injects a special solution to the fat tissue. The solution consists of anesthetics to reduce pain. Adrenalin to reduce bleeding and fluid to help separate the fat from the tissue.
The tumescent technique - much larger amounts of solution is being injected. Surgeons use this method, which allows to inject large amounts of anesthetics, and therefore this kind of procedure can be done with local anesthetics. The operation usually takes longer than the first one (4-5 hours).
The super wet technique in which the amount of solution injected equals the amount of fat tissue removed. This method also takes longer time and has to be done with general anesthetics.
Ultrasound assisted lipoplasty is another technique in which sound waves targeted to fat tissue. The waves break the connection between the fat cells, which are then being removed by suction. This method can be used in areas with connective tissue like the back and male breasts and also in areas that require more precise suction.
After the surgery to avoid swelling the areas of the suction will have elastic bandages. The surgeon may also leave draining tubes to prevent fluid collection. You might also receive antibiotics to prevent an infection.
Every surgery has its complications. In liposuction of 5 liter of fat and more there is a risk of fat or clot emboli to the lungs and even death. Extra fluids might be difficult to remove. The suction tube may cause skin necrosis or alter sensation in the area due to nerve damage. The ultrasound technique regarded as relatively safe produces, but it is a new one therefore the long term damage still unknown. In general, the surgery presents an extra rick for patients with diabetes, lung and heart disease and for those who had similar procedure in the past.
More Geneva info...
Geneva By car
If you want to explore the mountainous countryside, or go skiing in one of the ski resorts in the Alps, getting a car is a better option. Numerous local and international car rental service providers operate from the airport. They provide customized traveling services to the needs of tourists visiting Geneva. You can find public parking in Place de Cornavin, at the southern end of the Mt. Blanc bridge, and under the Plaine de Plainpalais. It's much easier to get a space at one of these large underground lots than on the street, and they are all convenient to most of the attractions listed on this page.
-
Geneva Understand
In 1536 a young man named Jean Calvin, fleeing Catholic persecution in France, spent a night in Geneva- the city he ended up spending his life in. After being expelled from Geneva for nearly three years, Calvin returned triumphantly in 1541 to help elevate the city to the rank of a Protestant Rome. The intellectual influence of the Reformation extended to all realms of Genevan life: politics, economy and administration.
-
LiposuctionLatest Forum Posts...
- Hello! I have friends whose daughters are getting so interested in lipo. Does anyone know if there is any age requirement for lipo? Is it safe for younger people? Thanks!
Plastic Surgery News...
- This review examines the evidence on rivaroxaban (Xarelto®), an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism (VTE) in patients undergoing major orthopaedic surgery of the lower limbs. A licence application was submitted to the EMEA in November 2007.
The review notes that limited data from the phase III RECORD studies (available in abstract form only) suggest that:
• Daily oral rivaroxaban 10mg is statistically significantly more effective than subcutaneous (s.c.) enoxaparin 40mg for short term thromboprophylaxis in patients undergoing total knee replacement; the primary endpoint (composite of DVT, non-fatal PE , and all-cause mortality) occurred in 9.6% and 18.9% of patients assigned to rivaroxaban or enoxaparin, respectively (p < 0.001).
• In extended thromboprophylaxis for hip arthroplasty, the same primary endpoint was achieved in 1.1% of rivaroxaban patients vs. 3.7% of those receiving enoxaparin (p < 0.001).
• Rivaroxaban and enoxaparin recipients experienced a similar incidence of major bleeding events, ranging from 0.1% to 0.6%.
No phase III liver function test data are available, but phase II data suggest that increases in liver enzymes seen in rivaroxaban recipients were of a similar order to enoxaparin recipients after 5–9 days of treatment. However caution is required until further information is available regarding safety. The review concludes “should efficacy and safety data prove favourable for oral rivoroxaban, and depending on cost, the drug might be particularly appropriate for those patients undergoing extended thromboprophylaxis after hip surgery. There will be no necessity to monitor patients for heparin-induced thrombocytopenia and a reduction in at home nurse visits may be possible. Hence, staff capacity may be released. Economic decisions concerning rivaroxaban uptake will need to balance the possible increase in drug costs versus the possible benefits that may accrue.”
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) today announced the release of new health information to raise awareness about diabetes, digestive diseases, and kidney and urologic diseases among people not yet diagnosed with these illnesses. The NIDDK developed the Awareness and Prevention Series for community health fairs, workplace health forums, family reunions, and other similar events. NIDDK is one of the National Institutes of Health (NIH).